Aleixo, G., Hartner, L. P., Diamond, M., Nziga, L., Lefler, D. S. (2025). Liposomal vs conventional doxorubicin as first-line therapy in advanced soft tissue sarcomas: A tertiary US center’s 8.5-year experience.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.e23533